美亚光电(002690) - 2015年7月22日投资者关系活动记录表

Group 1: Sales Performance - The company's self-developed oral X-ray CT diagnostic machine series has broken foreign monopolies and filled domestic gaps since its market launch in the second half of 2012, receiving enthusiastic welcome from domestic dental medical institutions, especially private dental hospitals/clinics, leading to rapid sales revenue growth [1][2] - With further market expansion and increasing societal demand for dental treatment, the company expects continued strong sales growth for its oral X-ray CT diagnostic machine series in the coming years [2] Group 2: R&D in High-end Medical Imaging - Following the successful launch of the oral X-ray CT diagnostic machine series, the company has increased its R&D investment in high-end medical imaging, successfully developing several new high-end medical imaging devices, including a self-developed skeletal CT device currently in clinical validation [2] - The company aims to replace imports and fill domestic gaps in high-end medical imaging equipment, with plans to continue increasing R&D investment in this field to develop more market-demanded products [2] Group 3: Strategic Cooperation - The company has signed a strategic cooperation framework agreement with the Hefei Research Institute of the Chinese Academy of Sciences, aimed at promoting the high-end precision radiotherapy industry represented by proton therapy and related medical equipment [3] - The cooperation will focus on R&D and manufacturing of high-end medical imaging equipment, high-end precision radiation therapy systems, medical imaging big data, and remote diagnosis services, which will enhance the company's industry layout and overall competitiveness [3] Group 4: Future Investment Directions - The company plans to increase investments in high-end medical imaging and industrial inspection fields while ensuring continuous innovation and stable development of its core color selection machine business [4] - Future mergers and acquisitions must enhance the company's core competitiveness and benefit product sales channels and market expansion [4]